“…However, results of a survey concerning current MFC practice in 229 laboratories around the world showed that although many laboratories used large numbers of markers in MFC workup of MDS (median: 20 ± 4.5), the compliance with i MDSflow recommendations was low, and proposed scoring systems were not widely applied (Grille Montauban et al, 2019; Jensen et al, 2019). With the hope of increasing the harmonization of MFC MDS diagnostics, the current paper presents a summary of the progress in this field and an update on consensus i MDSFlow guidelines for the assessment of significant anomalies in various bone marrow (BM) cell compartments for MFC features of dysplasia as a part of a special Issue of Clinical Cytometry B, focused on MFC applications in MDS and MDS/MPN (Kern et al, 2022; van de Loosdrecht et al, 2023; van der Velden et al, 2023; Wagner‐Ballon et al, 2023; Westers et al, 2021; Westers et al, 2023).…”